John Tentler
Concepts (387)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pyrimidines | 8 | 2020 | 459 | 1.510 |
Why?
| Xenograft Model Antitumor Assays | 21 | 2020 | 814 | 1.330 |
Why?
| Triple Negative Breast Neoplasms | 5 | 2020 | 197 | 1.310 |
Why?
| Protein Kinase Inhibitors | 15 | 2020 | 891 | 1.310 |
Why?
| Antineoplastic Agents | 18 | 2019 | 2061 | 1.220 |
Why?
| Colorectal Neoplasms | 11 | 2018 | 752 | 1.030 |
Why?
| Proto-Oncogene Proteins | 10 | 2018 | 638 | 0.970 |
Why?
| Azepines | 4 | 2020 | 89 | 0.890 |
Why?
| Piperazines | 4 | 2020 | 342 | 0.870 |
Why?
| Quinoxalines | 2 | 2020 | 65 | 0.830 |
Why?
| Pyrazoles | 4 | 2018 | 405 | 0.820 |
Why?
| Melanoma | 10 | 2018 | 730 | 0.790 |
Why?
| Gene Expression Regulation, Neoplastic | 9 | 2020 | 1356 | 0.770 |
Why?
| Mice, Nude | 16 | 2020 | 683 | 0.700 |
Why?
| Cell Proliferation | 21 | 2020 | 2391 | 0.650 |
Why?
| beta Catenin | 2 | 2020 | 223 | 0.640 |
Why?
| Enoyl-CoA Hydratase | 1 | 2018 | 8 | 0.620 |
Why?
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 211 | 0.600 |
Why?
| DNA-Binding Proteins | 8 | 2015 | 1443 | 0.560 |
Why?
| Cell Line, Tumor | 24 | 2020 | 3215 | 0.550 |
Why?
| Benzimidazoles | 4 | 2013 | 162 | 0.530 |
Why?
| Tumor Microenvironment | 1 | 2020 | 634 | 0.520 |
Why?
| Mutation | 11 | 2018 | 3717 | 0.500 |
Why?
| Cardiomyopathy, Dilated | 1 | 2018 | 381 | 0.480 |
Why?
| Tumor Suppressor Proteins | 2 | 2015 | 317 | 0.480 |
Why?
| Tumor Suppressor Protein p53 | 4 | 2016 | 511 | 0.470 |
Why?
| ras Proteins | 3 | 2013 | 144 | 0.440 |
Why?
| Genomics | 1 | 2018 | 716 | 0.430 |
Why?
| Pyrazines | 5 | 2013 | 86 | 0.420 |
Why?
| Proto-Oncogene Proteins B-raf | 4 | 2018 | 212 | 0.400 |
Why?
| Apoptosis | 13 | 2020 | 2503 | 0.380 |
Why?
| Oncogene Proteins, Fusion | 3 | 2018 | 201 | 0.370 |
Why?
| Drug Design | 1 | 2012 | 156 | 0.360 |
Why?
| Biomarkers, Tumor | 3 | 2017 | 1181 | 0.360 |
Why?
| Prolactin | 7 | 2004 | 98 | 0.340 |
Why?
| Mice | 21 | 2020 | 16937 | 0.340 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 131 | 0.340 |
Why?
| Nuclear Proteins | 1 | 2015 | 663 | 0.340 |
Why?
| Histone Deacetylase Inhibitors | 3 | 2022 | 209 | 0.330 |
Why?
| Drug Resistance, Neoplasm | 8 | 2020 | 759 | 0.330 |
Why?
| Aurora Kinase A | 4 | 2020 | 55 | 0.330 |
Why?
| Animals | 44 | 2020 | 35362 | 0.290 |
Why?
| Cell Transformation, Neoplastic | 4 | 2013 | 328 | 0.280 |
Why?
| Neoplasms | 4 | 2022 | 2470 | 0.280 |
Why?
| Imidazoles | 4 | 2013 | 234 | 0.280 |
Why?
| Pituitary Gland | 7 | 2003 | 148 | 0.280 |
Why?
| Hydroxamic Acids | 3 | 2011 | 88 | 0.260 |
Why?
| Ethanol | 11 | 1997 | 589 | 0.250 |
Why?
| Gene Expression Profiling | 6 | 2018 | 1706 | 0.250 |
Why?
| Exome | 2 | 2017 | 220 | 0.240 |
Why?
| Ubiquitin-Activating Enzymes | 2 | 2016 | 16 | 0.240 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2020 | 1565 | 0.230 |
Why?
| Breast Neoplasms | 3 | 2012 | 2142 | 0.230 |
Why?
| Transcription Factors | 4 | 2011 | 1651 | 0.230 |
Why?
| Pyrimidinones | 2 | 2015 | 103 | 0.230 |
Why?
| Pyridones | 2 | 2015 | 159 | 0.210 |
Why?
| Receptor, IGF Type 1 | 3 | 2013 | 65 | 0.210 |
Why?
| Cell Cycle Proteins | 3 | 2018 | 586 | 0.200 |
Why?
| Humans | 44 | 2022 | 129650 | 0.200 |
Why?
| Hypothalamus | 12 | 1997 | 149 | 0.190 |
Why?
| Immunoblotting | 5 | 2015 | 305 | 0.190 |
Why?
| Drug Synergism | 4 | 2018 | 371 | 0.180 |
Why?
| Tumor Cells, Cultured | 3 | 2020 | 940 | 0.180 |
Why?
| c-Mer Tyrosine Kinase | 2 | 2018 | 44 | 0.180 |
Why?
| G2 Phase Cell Cycle Checkpoints | 3 | 2018 | 45 | 0.180 |
Why?
| Female | 27 | 2020 | 68776 | 0.170 |
Why?
| Transcription, Genetic | 4 | 2013 | 1418 | 0.170 |
Why?
| Benzoxazoles | 1 | 2020 | 20 | 0.170 |
Why?
| Breast | 3 | 2018 | 153 | 0.170 |
Why?
| Boronic Acids | 2 | 2011 | 37 | 0.170 |
Why?
| Wnt Signaling Pathway | 2 | 2019 | 170 | 0.170 |
Why?
| Signal Transduction | 10 | 2018 | 4925 | 0.160 |
Why?
| Growth Hormone | 3 | 1997 | 96 | 0.160 |
Why?
| eIF-2 Kinase | 1 | 2019 | 30 | 0.160 |
Why?
| Sequence Analysis, RNA | 2 | 2018 | 429 | 0.160 |
Why?
| Epithelial Cells | 4 | 2011 | 1065 | 0.160 |
Why?
| Proto-Oncogene Proteins p21(ras) | 4 | 2016 | 259 | 0.150 |
Why?
| Cell Cycle | 7 | 2018 | 592 | 0.150 |
Why?
| Breast Neoplasms, Male | 1 | 2018 | 29 | 0.150 |
Why?
| Linkage Disequilibrium | 1 | 2018 | 257 | 0.150 |
Why?
| MAP Kinase Kinase Kinases | 2 | 2015 | 71 | 0.150 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2018 | 151 | 0.150 |
Why?
| Septins | 1 | 2018 | 43 | 0.140 |
Why?
| Mice, Inbred BALB C | 1 | 2020 | 1245 | 0.140 |
Why?
| Drug Therapy, Combination | 1 | 2020 | 1040 | 0.140 |
Why?
| Genetics, Population | 1 | 2018 | 200 | 0.140 |
Why?
| Cytoskeleton | 1 | 2018 | 183 | 0.140 |
Why?
| Neurofibromin 1 | 1 | 2017 | 25 | 0.140 |
Why?
| Gonadotropin-Releasing Hormone | 8 | 1993 | 207 | 0.140 |
Why?
| Somatostatin | 1 | 1997 | 55 | 0.140 |
Why?
| Armadillo Domain Proteins | 1 | 2017 | 6 | 0.140 |
Why?
| Testis | 2 | 1997 | 144 | 0.130 |
Why?
| RNA Splicing Factors | 1 | 2017 | 52 | 0.130 |
Why?
| Proto-Oncogene Proteins c-kit | 1 | 2017 | 68 | 0.130 |
Why?
| Proto-Oncogene Proteins c-ret | 1 | 2017 | 30 | 0.130 |
Why?
| Sexual Maturation | 1 | 1997 | 52 | 0.130 |
Why?
| Inhibitory Concentration 50 | 2 | 2016 | 86 | 0.130 |
Why?
| Cyclopentanes | 1 | 2016 | 19 | 0.130 |
Why?
| Adenine | 1 | 2018 | 256 | 0.130 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 1997 | 141 | 0.130 |
Why?
| Gene Regulatory Networks | 1 | 2018 | 284 | 0.130 |
Why?
| Mucous Membrane | 1 | 2017 | 122 | 0.130 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 133 | 0.130 |
Why?
| Genes, erbB-1 | 1 | 2016 | 17 | 0.130 |
Why?
| RNA, Messenger | 10 | 2003 | 2708 | 0.130 |
Why?
| Oligonucleotide Array Sequence Analysis | 3 | 2015 | 769 | 0.120 |
Why?
| Education, Graduate | 1 | 2015 | 34 | 0.120 |
Why?
| Drug Discovery | 1 | 2016 | 131 | 0.120 |
Why?
| HT29 Cells | 2 | 2018 | 36 | 0.120 |
Why?
| Peptides, Cyclic | 1 | 1997 | 256 | 0.120 |
Why?
| Skin Neoplasms | 2 | 2013 | 825 | 0.120 |
Why?
| Tumor Protein p73 | 1 | 2015 | 14 | 0.120 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2013 | 148 | 0.120 |
Why?
| Neoplasm Invasiveness | 3 | 2018 | 485 | 0.120 |
Why?
| Phosphoproteins | 1 | 2017 | 332 | 0.120 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2014 | 312 | 0.120 |
Why?
| Computational Biology | 2 | 2016 | 599 | 0.110 |
Why?
| Luteinizing Hormone | 8 | 1993 | 179 | 0.110 |
Why?
| Cluster Analysis | 2 | 2012 | 482 | 0.110 |
Why?
| Testosterone | 2 | 1997 | 372 | 0.110 |
Why?
| Case-Control Studies | 2 | 2018 | 3381 | 0.110 |
Why?
| Phosphorylation | 5 | 2019 | 1713 | 0.110 |
Why?
| Protein Kinases | 1 | 2015 | 318 | 0.110 |
Why?
| Genotype | 1 | 2018 | 1839 | 0.110 |
Why?
| Receptor, Insulin | 1 | 2013 | 99 | 0.110 |
Why?
| Protein-Tyrosine Kinases | 1 | 2017 | 432 | 0.100 |
Why?
| Phenotype | 3 | 2018 | 3076 | 0.100 |
Why?
| Ubiquitin-Conjugating Enzymes | 1 | 2013 | 13 | 0.100 |
Why?
| Cell Survival | 4 | 2019 | 1086 | 0.100 |
Why?
| Tumor Stem Cell Assay | 1 | 2012 | 32 | 0.100 |
Why?
| Aurora Kinases | 1 | 2012 | 29 | 0.100 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 69 | 0.100 |
Why?
| BRCA1 Protein | 1 | 2013 | 65 | 0.100 |
Why?
| Proto-Oncogene Proteins c-ets | 4 | 2011 | 53 | 0.100 |
Why?
| Alcohol Oxidoreductases | 1 | 2013 | 60 | 0.100 |
Why?
| Mitochondria | 1 | 2018 | 877 | 0.100 |
Why?
| Rats | 21 | 2004 | 5500 | 0.100 |
Why?
| Genes, p53 | 1 | 2012 | 70 | 0.100 |
Why?
| Positron-Emission Tomography | 2 | 2011 | 288 | 0.100 |
Why?
| MicroRNAs | 1 | 2018 | 678 | 0.100 |
Why?
| Receptor, ErbB-2 | 2 | 2012 | 326 | 0.100 |
Why?
| Cyclosporine | 1 | 2013 | 263 | 0.100 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2014 | 396 | 0.090 |
Why?
| Proto-Oncogene Proteins c-met | 1 | 2012 | 74 | 0.090 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2013 | 153 | 0.090 |
Why?
| Drug Screening Assays, Antitumor | 4 | 2016 | 195 | 0.090 |
Why?
| Proteasome Inhibitors | 1 | 2011 | 42 | 0.090 |
Why?
| Mammary Glands, Human | 1 | 2011 | 64 | 0.090 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2018 | 2073 | 0.090 |
Why?
| Receptor Protein-Tyrosine Kinases | 1 | 2013 | 231 | 0.090 |
Why?
| Cellular Senescence | 1 | 2012 | 181 | 0.090 |
Why?
| Transcriptional Activation | 2 | 2003 | 366 | 0.090 |
Why?
| Cytoplasm | 1 | 2011 | 263 | 0.090 |
Why?
| Recombinant Fusion Proteins | 2 | 2011 | 643 | 0.090 |
Why?
| Cell Movement | 3 | 2011 | 945 | 0.090 |
Why?
| Protease Inhibitors | 1 | 2011 | 106 | 0.090 |
Why?
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2009 | 7 | 0.080 |
Why?
| Ki-67 Antigen | 1 | 2010 | 109 | 0.080 |
Why?
| Neoplasm Transplantation | 3 | 2016 | 257 | 0.080 |
Why?
| Capillary Permeability | 1 | 2010 | 139 | 0.080 |
Why?
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 70 | 0.080 |
Why?
| Adenocarcinoma | 1 | 2016 | 898 | 0.080 |
Why?
| Gastrointestinal Neoplasms | 1 | 2009 | 72 | 0.080 |
Why?
| Carcinoma, Hepatocellular | 1 | 2011 | 272 | 0.080 |
Why?
| Cell Line | 4 | 2012 | 2781 | 0.080 |
Why?
| Quinazolines | 1 | 2009 | 244 | 0.070 |
Why?
| Promoter Regions, Genetic | 3 | 2004 | 1207 | 0.070 |
Why?
| Peptide Fragments | 1 | 2011 | 692 | 0.070 |
Why?
| Algorithms | 2 | 2015 | 1622 | 0.070 |
Why?
| Drug Delivery Systems | 1 | 2010 | 336 | 0.070 |
Why?
| Enzyme Inhibitors | 3 | 2013 | 827 | 0.070 |
Why?
| Pituitary Gland, Anterior | 4 | 1992 | 39 | 0.070 |
Why?
| Prognosis | 2 | 2017 | 3794 | 0.070 |
Why?
| Colonic Neoplasms | 1 | 2009 | 243 | 0.070 |
Why?
| Proto-Oncogene Protein c-ets-1 | 2 | 2003 | 19 | 0.060 |
Why?
| Disease Models, Animal | 2 | 2014 | 4063 | 0.060 |
Why?
| Reproducibility of Results | 2 | 2010 | 3083 | 0.060 |
Why?
| Growth Hormone-Releasing Hormone | 2 | 1997 | 24 | 0.060 |
Why?
| Rats, Inbred Strains | 12 | 1992 | 368 | 0.060 |
Why?
| Transplantation, Heterologous | 2 | 2016 | 192 | 0.060 |
Why?
| Oncogene Protein p65(gag-jun) | 1 | 2004 | 2 | 0.060 |
Why?
| Male | 25 | 2020 | 63681 | 0.060 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2004 | 52 | 0.060 |
Why?
| Gene Expression Regulation | 2 | 2004 | 2548 | 0.060 |
Why?
| Transfection | 2 | 2003 | 911 | 0.050 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 487 | 0.050 |
Why?
| Pancreatic Neoplasms | 1 | 2011 | 882 | 0.050 |
Why?
| Transcription Factor Pit-1 | 1 | 2003 | 24 | 0.050 |
Why?
| Suppression, Genetic | 1 | 2003 | 25 | 0.050 |
Why?
| Disease Progression | 3 | 2018 | 2635 | 0.050 |
Why?
| Lung Neoplasms | 1 | 2016 | 2344 | 0.050 |
Why?
| Mesoderm | 1 | 2004 | 137 | 0.050 |
Why?
| Genes, Dominant | 1 | 2003 | 92 | 0.050 |
Why?
| Histone Deacetylase 1 | 1 | 2022 | 24 | 0.050 |
Why?
| DNA Repair | 2 | 2013 | 207 | 0.050 |
Why?
| Middle Aged | 6 | 2020 | 31154 | 0.050 |
Why?
| Caspase 3 | 2 | 2013 | 245 | 0.050 |
Why?
| Blotting, Northern | 3 | 1997 | 200 | 0.050 |
Why?
| Aged | 5 | 2020 | 22103 | 0.050 |
Why?
| DNA Damage | 2 | 2013 | 384 | 0.050 |
Why?
| Acetylation | 1 | 2022 | 246 | 0.050 |
Why?
| Repressor Proteins | 1 | 2004 | 406 | 0.040 |
Why?
| Radioimmunoassay | 8 | 1993 | 175 | 0.040 |
Why?
| Histone Deacetylases | 1 | 2022 | 212 | 0.040 |
Why?
| Bortezomib | 2 | 2011 | 45 | 0.040 |
Why?
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 62 | 0.040 |
Why?
| Maximum Tolerated Dose | 1 | 2020 | 193 | 0.040 |
Why?
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 119 | 0.040 |
Why?
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2019 | 40 | 0.040 |
Why?
| Blotting, Western | 3 | 2010 | 1205 | 0.040 |
Why?
| Gene Expression | 3 | 1993 | 1472 | 0.040 |
Why?
| M Phase Cell Cycle Checkpoints | 1 | 2018 | 24 | 0.040 |
Why?
| Azetidines | 1 | 2018 | 40 | 0.040 |
Why?
| Spleen | 2 | 1991 | 507 | 0.040 |
Why?
| Lymphocytes | 2 | 1991 | 377 | 0.040 |
Why?
| GTP Phosphohydrolases | 1 | 2018 | 85 | 0.040 |
Why?
| 4-Aminobenzoic Acid | 1 | 2018 | 7 | 0.040 |
Why?
| Nausea | 1 | 2018 | 110 | 0.040 |
Why?
| HCT116 Cells | 1 | 2018 | 78 | 0.040 |
Why?
| Okadaic Acid | 1 | 1997 | 14 | 0.040 |
Why?
| Orchiectomy | 4 | 1994 | 67 | 0.040 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 833 | 0.030 |
Why?
| Colforsin | 1 | 1997 | 50 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 2 | 2011 | 361 | 0.030 |
Why?
| Diarrhea | 1 | 2018 | 180 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 3 | 1997 | 2012 | 0.030 |
Why?
| Piperidines | 1 | 2018 | 199 | 0.030 |
Why?
| Angiogenesis Inhibitors | 1 | 2018 | 220 | 0.030 |
Why?
| Tumor Burden | 1 | 2018 | 286 | 0.030 |
Why?
| Histones | 1 | 2022 | 588 | 0.030 |
Why?
| Cells, Cultured | 4 | 2013 | 4083 | 0.030 |
Why?
| Ubiquitination | 1 | 2016 | 98 | 0.030 |
Why?
| Cell Differentiation | 1 | 2004 | 1902 | 0.030 |
Why?
| Fatigue | 1 | 2018 | 318 | 0.030 |
Why?
| Heterografts | 1 | 2016 | 131 | 0.030 |
Why?
| Treatment Outcome | 1 | 2010 | 10230 | 0.030 |
Why?
| Cetuximab | 1 | 2016 | 94 | 0.030 |
Why?
| Administration, Oral | 1 | 2018 | 786 | 0.030 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 117 | 0.030 |
Why?
| Protein Isoforms | 1 | 2017 | 391 | 0.030 |
Why?
| Camptothecin | 1 | 2016 | 109 | 0.030 |
Why?
| Gene Rearrangement | 1 | 2017 | 148 | 0.030 |
Why?
| Polymerase Chain Reaction | 3 | 1993 | 1038 | 0.030 |
Why?
| Aged, 80 and over | 2 | 2017 | 7086 | 0.030 |
Why?
| Models, Educational | 1 | 2015 | 88 | 0.030 |
Why?
| Capacity Building | 1 | 2015 | 59 | 0.030 |
Why?
| DNA Copy Number Variations | 1 | 2016 | 170 | 0.030 |
Why?
| Diphenylamine | 1 | 2014 | 9 | 0.030 |
Why?
| DNA Mutational Analysis | 1 | 2016 | 387 | 0.030 |
Why?
| Biopsy | 1 | 2018 | 1097 | 0.030 |
Why?
| Interdisciplinary Communication | 1 | 2015 | 186 | 0.030 |
Why?
| Follicle Stimulating Hormone | 2 | 1993 | 236 | 0.030 |
Why?
| Databases, Genetic | 1 | 2015 | 232 | 0.030 |
Why?
| Guanine | 1 | 1994 | 76 | 0.030 |
Why?
| Research Personnel | 1 | 2015 | 156 | 0.030 |
Why?
| Neoplasm Metastasis | 1 | 2016 | 610 | 0.030 |
Why?
| Analysis of Variance | 1 | 1997 | 1288 | 0.030 |
Why?
| Methyltransferases | 1 | 1994 | 70 | 0.030 |
Why?
| Gonadotropins | 1 | 1993 | 38 | 0.030 |
Why?
| Benzamides | 1 | 2014 | 207 | 0.030 |
Why?
| Adult | 4 | 2018 | 35576 | 0.030 |
Why?
| Caspase 7 | 1 | 2013 | 22 | 0.030 |
Why?
| Mentors | 1 | 2015 | 178 | 0.030 |
Why?
| Butadienes | 1 | 2013 | 36 | 0.030 |
Why?
| MAP Kinase Kinase 2 | 1 | 2013 | 29 | 0.030 |
Why?
| Program Development | 1 | 2015 | 357 | 0.030 |
Why?
| MAP Kinase Kinase 1 | 1 | 2013 | 76 | 0.030 |
Why?
| Kinetics | 2 | 2014 | 1642 | 0.030 |
Why?
| Cell Cycle Checkpoints | 1 | 2013 | 95 | 0.030 |
Why?
| Oncogene Proteins, Viral | 1 | 2013 | 22 | 0.030 |
Why?
| Molecular Sequence Data | 3 | 2011 | 2832 | 0.030 |
Why?
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 73 | 0.030 |
Why?
| Cooperative Behavior | 1 | 2015 | 433 | 0.030 |
Why?
| Melanocytes | 1 | 2013 | 64 | 0.030 |
Why?
| Nitriles | 1 | 2013 | 172 | 0.020 |
Why?
| Drug Hypersensitivity | 1 | 1993 | 81 | 0.020 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 359 | 0.020 |
Why?
| Genes, Synthetic | 1 | 2012 | 14 | 0.020 |
Why?
| Genes, Lethal | 1 | 2012 | 29 | 0.020 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 64 | 0.020 |
Why?
| DNA, Neoplasm | 1 | 2013 | 159 | 0.020 |
Why?
| Membrane Proteins | 1 | 2018 | 1119 | 0.020 |
Why?
| Mice, SCID | 1 | 2013 | 351 | 0.020 |
Why?
| Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 66 | 0.020 |
Why?
| Precision Medicine | 1 | 2016 | 387 | 0.020 |
Why?
| Nuclear Export Signals | 1 | 2011 | 4 | 0.020 |
Why?
| Glycoprotein Hormones, alpha Subunit | 1 | 1991 | 22 | 0.020 |
Why?
| Nuclear Localization Signals | 1 | 2011 | 15 | 0.020 |
Why?
| Alcoholic Intoxication | 1 | 1992 | 63 | 0.020 |
Why?
| Peptide Mapping | 1 | 2011 | 63 | 0.020 |
Why?
| Microscopy, Fluorescence | 1 | 2013 | 400 | 0.020 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 375 | 0.020 |
Why?
| Calcium Signaling | 1 | 2013 | 250 | 0.020 |
Why?
| Amino Acid Motifs | 1 | 2011 | 213 | 0.020 |
Why?
| Colony-Forming Units Assay | 1 | 2010 | 90 | 0.020 |
Why?
| Amino Acid Substitution | 1 | 2011 | 282 | 0.020 |
Why?
| Culture Media, Conditioned | 1 | 2010 | 110 | 0.020 |
Why?
| Genes, ras | 1 | 2010 | 97 | 0.020 |
Why?
| Protein Biosynthesis | 1 | 1992 | 406 | 0.020 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2011 | 257 | 0.020 |
Why?
| Protein Transport | 1 | 2011 | 428 | 0.020 |
Why?
| Ligands | 1 | 2011 | 622 | 0.020 |
Why?
| Gene Dosage | 1 | 2010 | 143 | 0.020 |
Why?
| Drug Combinations | 1 | 2010 | 330 | 0.020 |
Why?
| Transcriptome | 1 | 2015 | 887 | 0.020 |
Why?
| Structure-Activity Relationship | 1 | 2010 | 548 | 0.020 |
Why?
| Gene Knockdown Techniques | 1 | 2010 | 315 | 0.020 |
Why?
| Hypertension | 1 | 2018 | 1242 | 0.020 |
Why?
| Curriculum | 1 | 2015 | 917 | 0.020 |
Why?
| Prolactinoma | 1 | 1989 | 12 | 0.020 |
Why?
| Serum Albumin | 1 | 1990 | 149 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2011 | 840 | 0.020 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2011 | 539 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2013 | 1698 | 0.020 |
Why?
| Cell Communication | 1 | 2010 | 301 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 431 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2017 | 4897 | 0.020 |
Why?
| Pregnanediones | 1 | 1987 | 7 | 0.020 |
Why?
| Rats, Sprague-Dawley | 4 | 1994 | 2406 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2011 | 2058 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 958 | 0.020 |
Why?
| Sulfonamides | 1 | 2011 | 496 | 0.020 |
Why?
| Brain Chemistry | 1 | 1987 | 118 | 0.020 |
Why?
| Anesthetics | 1 | 1987 | 66 | 0.020 |
Why?
| Pituitary Neoplasms | 1 | 1989 | 184 | 0.020 |
Why?
| Calcium | 1 | 2013 | 1213 | 0.020 |
Why?
| Feasibility Studies | 1 | 2010 | 868 | 0.020 |
Why?
| Estrogens | 1 | 1989 | 347 | 0.020 |
Why?
| Liver Neoplasms | 1 | 2011 | 640 | 0.020 |
Why?
| Models, Biological | 1 | 2013 | 1722 | 0.020 |
Why?
| Metabolomics | 1 | 2011 | 652 | 0.020 |
Why?
| Flow Cytometry | 1 | 2009 | 1156 | 0.020 |
Why?
| Prostatic Neoplasms | 1 | 2013 | 1016 | 0.010 |
Why?
| Proto-Oncogene Protein c-ets-2 | 1 | 2004 | 3 | 0.010 |
Why?
| Contact Inhibition | 1 | 2004 | 5 | 0.010 |
Why?
| Oncogene Protein p21(ras) | 1 | 2004 | 16 | 0.010 |
Why?
| Epidermal Growth Factor | 1 | 2004 | 171 | 0.010 |
Why?
| Antisense Elements (Genetics) | 1 | 2003 | 4 | 0.010 |
Why?
| Collagenases | 1 | 2003 | 23 | 0.010 |
Why?
| Matrix Metalloproteinase 3 | 1 | 2003 | 26 | 0.010 |
Why?
| Genetic Vectors | 1 | 2004 | 312 | 0.010 |
Why?
| Cell Adhesion | 1 | 2004 | 452 | 0.010 |
Why?
| Cytokines | 1 | 2010 | 2017 | 0.010 |
Why?
| Cell Division | 1 | 2004 | 797 | 0.010 |
Why?
| Trans-Activators | 1 | 2004 | 388 | 0.010 |
Why?
| HeLa Cells | 1 | 2003 | 608 | 0.010 |
Why?
| Brain | 1 | 1992 | 2679 | 0.010 |
Why?
| Potassium | 2 | 1990 | 143 | 0.010 |
Why?
| Base Sequence | 2 | 1993 | 2142 | 0.010 |
Why?
| Biological Assay | 2 | 1990 | 118 | 0.010 |
Why?
| Hypophysectomy | 2 | 1987 | 15 | 0.010 |
Why?
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 1994 | 6 | 0.010 |
Why?
| Cocarcinogenesis | 1 | 1994 | 14 | 0.010 |
Why?
| Injections, Intraperitoneal | 1 | 1994 | 111 | 0.010 |
Why?
| Rats, Mutant Strains | 1 | 1993 | 24 | 0.010 |
Why?
| Thyrotropin | 1 | 1994 | 109 | 0.010 |
Why?
| Stress, Physiological | 2 | 1987 | 413 | 0.010 |
Why?
| RNA-Directed DNA Polymerase | 1 | 1993 | 34 | 0.010 |
Why?
| Adrenocorticotropic Hormone | 1 | 1994 | 133 | 0.010 |
Why?
| Blotting, Southern | 1 | 1992 | 69 | 0.010 |
Why?
| Cyclic AMP | 1 | 1992 | 237 | 0.010 |
Why?
| Protein Kinase C | 1 | 1992 | 259 | 0.010 |
Why?
| Enzyme Activation | 1 | 1992 | 811 | 0.010 |
Why?
| RNA Splicing | 1 | 1992 | 262 | 0.010 |
Why?
| Cross Reactions | 1 | 1990 | 132 | 0.010 |
Why?
| Dinoprostone | 1 | 1990 | 186 | 0.000 |
Why?
| Bromocriptine | 1 | 1989 | 29 | 0.000 |
Why?
| Norepinephrine | 1 | 1990 | 210 | 0.000 |
Why?
| Perfusion | 1 | 1990 | 197 | 0.000 |
Why?
| Naloxone | 1 | 1990 | 112 | 0.000 |
Why?
| Rats, Inbred F344 | 1 | 1989 | 257 | 0.000 |
Why?
| Depression, Chemical | 1 | 1987 | 22 | 0.000 |
Why?
| In Vitro Techniques | 1 | 1990 | 1085 | 0.000 |
Why?
| Chromatography, High Pressure Liquid | 1 | 1990 | 582 | 0.000 |
Why?
| Urethane | 1 | 1987 | 41 | 0.000 |
Why?
| Pancreas | 1 | 1990 | 306 | 0.000 |
Why?
| Molecular Weight | 1 | 1987 | 332 | 0.000 |
Why?
| Drug Administration Schedule | 1 | 1989 | 769 | 0.000 |
Why?
| Dopamine | 1 | 1990 | 289 | 0.000 |
Why?
| Ketamine | 1 | 1987 | 85 | 0.000 |
Why?
| Cerebral Cortex | 1 | 1990 | 437 | 0.000 |
Why?
| Alcoholism | 1 | 1992 | 766 | 0.000 |
Why?
| Restraint, Physical | 1 | 1986 | 68 | 0.000 |
Why?
| DNA | 1 | 1991 | 1401 | 0.000 |
Why?
| Kidney | 1 | 1990 | 1385 | 0.000 |
Why?
| Liver | 1 | 1990 | 1839 | 0.000 |
Why?
| Lung | 1 | 1990 | 3930 | 0.000 |
Why?
|
|
Tentler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|